Search results

Researchers based at Monash University and the Swedish Museum of Natural History have pioneered the use of nuclear imaging techniques at ANSTO’s Centre for Neutron Scattering to resolve long-standing problems in plant evolutionary history linked to wildfires.

A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.

ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.

Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .

ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).

Indigenous development program and nuclear science and engineering scholarships will be funded

Australia’s new state-of-the-art nuclear medicine facility gets green light.

A lesson in Science and Sustainability.

Meeting of minds about potential next-generation cancer treatment for Australians

The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

Government response to 2016 National Research Infrastructure Roadmap